Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped
Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...
Yahoo Finance2d
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped
Novo Nordisk owns two of them ... million units of vials and syringes for injections More than 1 billion oral tablets, for when it gets FDA approval to sell VK2735 in pill form.
New introductions and price growth driving pharma market growth
The pharma industry registered a 7.5% value growth year-on-year for the month of February, with sales of ₹18,781 crore, ...
Fierce Pharma3d
Viking pays $150M to recruit CordenPharma for obesity drug manufacturing saga
Less than a year after CordenPharma earmarked a major chunk of change to beef up in peptide manufacturing for GLP-1s and ...
The FDA Cracking Down on Compounded Weight Loss Drugs – Here’s What It Means for Telehealth Companies and Consumers
After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
The Globe and Mail18d
Wall Street Thinks This Weight-Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk
Novo Nordisk stock is up around 75% despite a pullback in recent ... Viking is also evaluating an oral tablet formulation of VK-2735 in phase 2 testing. The company thinks this tablet could be more ...
pharmaphorum3d
Oral insulin could still be a reality, says Novo Nordisk
therapeutically meaningful insulin in an easy-to-take oral tablet," said study co-author, Karsten Wassermann, PhD, DSc, project vice president of global development at Novo Nordisk. "Oral insulin ...